Clinical Trial

Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
1. Evaluate the efficacy and safety of Qidan Xiaohe granules in patients after coronary revascularization surgery; 2. Develop a traditional Chinese medicine rehabilitation treatment plan and evaluation system for the use of Qidan Xiaohe granules after coronary revascularization surgery; 3. Demonstrate the advantages of traditional Chinese medicine rehabilitation treatment in the postoperative management of coronary revascularization surgery and provide high-level evidence-based medical evidence for the development of traditional Chinese medicine rehabilitation treatment plans.
Trial Details
NCT Number NCT07616544
Lead Sponsor Liu Qiang
Conditions Percutaneous Coronary Intervention, Myocardial Revascularization, Coronary Artery Disease
Enrollment 164 participants
Start Date 2026-07-01
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-01